Evidence map›Paper›PMID 33752104›Full record

ArticleSexual medicine2021

YouTube as a Patient Education Resource for Male Hypogonadism and Testosterone Therapy.

Christopher J Warren, John Wisener, Brittany Ward, Sara Behbahani, Tejash Shah, Adam Fano, Boris Paskhover, Hossein Sadeghi-Nejad

Abstract read
In one paragraph

Article in Sexual medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. [Sexual health information on social media: a systematic scoping review].Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Christopher J WarrenDivision of Urology, Department of Surgery, Rutgers-New Jersey Medical School, Newark NJ, USA.
John WisenerDivision of Urology, Department of Surgery, Rutgers-New Jersey Medical School, Newark NJ, USA.
Brittany WardDivision of Urology, Department of Surgery, Rutgers-New Jersey Medical School, Newark NJ, USA.
Sara BehbahaniDivision of Urology, Department of Surgery, Rutgers-New Jersey Medical School, Newark NJ, USA.
Tejash ShahDivision of Urology, Department of Surgery, Rutgers-New Jersey Medical School, Newark NJ, USA.
Adam FanoDivision of Urology, Department of Surgery, Rutgers-New Jersey Medical School, Newark NJ, USA.
Boris PaskhoverDepartment of Otolaryngology, Rutgers-New Jersey Medical School, Newark NJ, USA.
Hossein Sadeghi-NejadDivision of Urology, Department of Surgery, Rutgers-New Jersey Medical School, Newark NJ, USA; Department of Urology, Hackensack UMC-Meridian Health, Hackensack NJ, USA. Electronic address: Hossein55@icloud.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionYouTube is an unregulated platform that patients are using to learn about treatment options.

aimTo assess the reliability of YouTube videos (YTVs) related to male hypogonadism and testosterone therapy.

methodsSearching on YouTube by relevance and view count, we analyzed the top 10 videos (80 videos total) for the following search terms: low testosterone, testosterone replacement therapy, AndroGel, and hypogonadism.

main outcome measureWe recorded the number of views for each video, evaluated videos using the DISCERN score (DS) criterion, and compared the DS for videos including board-certified physicians and videos without. A second comparison was made between videos with board-certified physicians in urology, endocrinology, other MD, and those without any physician.

resultsThe YTVs analyzed received a total of 38,549,090 views, a median of 25,201 and 17.30 views/day. Videos that featured physicians had significantly fewer views/day than videos that did not (39.48 CI 9,72 vs 1,731 CI 330, 3,132; P = .019). Most YTVs studied were unreliable. The median DS across all videos was 2. However, most videos created by physicians were found to be reliable with a median DS of 4. In addition, YTVs that did not feature a physician were found to be significantly less reliable than videos that featured a physician (3.22 CI 3.06, 4.09 vs 1.87 CI 1.56, 2.18; P < .001). There was no significant difference in the reliability or viewership of YTVs stratified by physician type.

conclusionMost YTVs related to male hypogonadism/testosterone therapy were unreliable, but there are reliable YTVs available. Reliable videos usually feature a physician and receive fewer views than unreliable YTVs. Physicians and academic societies should work to provide verified videos to provide patients with reliable information about male hypogonadism and testosterone therapy. CJ Warren, J Wisener, B Ward, et al. YouTube as a Patient Education Resource for Male Hypogonadism and Testosterone Therapy. Sex Med 2021;9:100324.

Indexed as

Male HypogonadismSocial MediaTestosterone TherapyYouTube

Identifiers

PMID33752104
PMCPMC8072170

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.